Dr. Martens is on track with its strategic objectives for fiscal year 2027. The company is focused on its ambition to become the world's most-desired premium footwear brand. Profit before taxes in fiscal 2026 increased 9.7 percent to 32.7 million pounds, up from 29.8 million pounds in fiscal year 2025. Revenue fell 1.5 percent to 764.9 million pounds from 776.3 million pounds. Americas was the best performing region, with EMEA posting good wholesale growth.